AVERY WARNER: Open Payments
NPI 1770213845 · EAST LONGMEADOW, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,837 in 125 payments from 21 companies in 2025. Trend: 2023 $3,183 · 2024 $2,714 · 2025 $2,837
Food & beverage: $2,837
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $898 |
| AstraZeneca Pharmaceuticals LP | 13 | $309 |
| Lilly USA, LLC | 9 | $287 |
| Novo Nordisk Inc | 11 | $242 |
| Phathom Pharmaceuticals, Inc. | 9 | $185 |
| Axsome Therapeutics, Inc. | 4 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $130 |
| PFIZER INC. | 5 | $115 |
| Astellas Pharma US Inc | 4 | $111 |
| Abbott Laboratories | 3 | $73 |
Products named: VRAYLAR, UBRELVY, AIRSUPRA, KISUNLA, VOQUEZNA, Auvelity, Wegovy, JARDIANCE.
Industry payments across MA — which companies pay providers there.
